Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PNT | AZN | AMGN | GILD | VRTX |
| Company | Point Biopharma Global Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 12.50 | 189.95 | 366.18 | 136.58 | 523.04 |
| High | 12.51 | 191.48 | 371.42 | 137.70 | 525.81 |
| Low | 12.49 | 188.66 | 363.00 | 134.00 | 498.14 |
| Latest | 12.50 | 189.28 | 367.99 | 135.82 | 498.43 |
| Change | +0.02 | -3.84 | -0.11 | -0.54 | -23.82 |
| % Change | +0.16% | -1.99% | -0.03% | -0.40% | -4.56% |
| Volume | 3,290,900 | 1,967,800 | 1,758,900 | 8,454,100 | 2,287,200 |
| 20-Day Average Volume | 4,214,580 | 2,006,895 | 3,127,335 | 8,969,890 | 1,990,660 |
| Previous Close | 12.48 | 193.12 | 368.10 | 136.36 | 522.25 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 13.45 | 183.95 | 354.21 | 126.88 | 477.02 |
| 20-Day Raw Stochastic | 3.65% | 68.67% | 82.38% | 88.47% | 64.71% |
| 20-Day Relative Strength | 42.56 | 52.92 | 60.89 | 58.59 | 60.33 |
| Weighted Alpha | +4.80 | +25.91 | +24.96 | +20.53 | +14.25 |
| Today's Opinion | 56% Buy | 8% Buy | 72% Buy | 8% Sell | 72% Buy |
| Previous Opinion | 56% Buy | 24% Buy | 72% Buy | 16% Sell | 72% Buy |
| Last Month's Opinion | 100% Buy | 8% Sell | 24% Buy | 24% Sell | Hold |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.40% since 12/18/23 | -0.18% since 06/30/26 | +1.62% since 06/30/26 | +7.50% since 06/30/26 | +0.34% since 06/30/26 |
| Low | 12.43 on 12/19/23 | 183.49 on 07/01/26 | 357.89 on 07/01/26 | 125.13 on 07/01/26 | 494.80 on 07/01/26 |
| High | 12.51 on 12/26/23 | 196.41 on 07/02/26 | 375.25 on 07/07/26 | 137.70 on 07/08/26 | 533.67 on 07/07/26 |
| 1-Month | |||||
| %Chg | -9.16% since 11/24/23 | +4.26% since 06/08/26 | +6.44% since 06/08/26 | +6.03% since 06/08/26 | +12.52% since 06/08/26 |
| Low | 12.43 on 12/19/23 | 173.65 on 06/18/26 | 334.05 on 06/18/26 | 121.39 on 06/10/26 | 433.80 on 06/10/26 |
| High | 14.35 on 12/13/23 | 196.41 on 07/02/26 | 375.25 on 07/07/26 | 137.70 on 07/08/26 | 533.67 on 07/07/26 |
| 3-Month | |||||
| %Chg | +83.28% since 09/26/23 | -7.34% since 04/08/26 | +5.20% since 04/08/26 | -4.04% since 04/08/26 | +12.28% since 04/08/26 |
| Low | 6.57 on 10/02/23 | 173.65 on 06/18/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 14.35 on 12/13/23 | 207.30 on 04/10/26 | 375.25 on 07/07/26 | 142.97 on 04/09/26 | 533.67 on 07/07/26 |
| 6-Month | |||||
| %Chg | +37.67% since 06/26/23 | +0.67% since 01/08/26 | +11.47% since 01/08/26 | +12.55% since 01/08/26 | +6.12% since 01/08/26 |
| Low | 6.57 on 10/02/23 | 173.65 on 06/18/26 | 319.79 on 01/13/26 | 119.33 on 01/09/26 | 412.27 on 05/05/26 |
| High | 14.35 on 12/13/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 533.67 on 07/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,332,113 | 293,555,872 | 198,607,136 | 168,630,048 | 126,504,016 |
| Shares Outstanding, K | 106,569 | 1,550,908 | 539,708 | 1,241,570 | 253,805 |
| Annual Sales | 226,580,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | 98,290,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 2,790,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 2,986,900,000 |
| Last Quarter Net Income | -24,770,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 1,031,400,000 |
| 60-Month Beta | 0.00 | 0.24 | 0.41 | 0.32 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.23 on 11/13/23 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 4.47 on 05/04/26 |
| Earnings Date | 03/25/24 | 07/27/26 | 08/04/26 | 08/06/26 | 08/03/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 13.87 | 20.86 | 16.66 | 16.29 | 31.05 |